Evidence map›Paper›PMID 31277439›Full record

ArticleJournal of clinical medicine2019

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells.

Valentina Rosso, Cristina Panuzzo, Jessica Petiti, Sonia Carturan, Matteo Dragani, Giacomo Andreani, Carmen Fava, Giuseppe Saglio, Enrico Bracco, Daniela Cilloni

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Valentina RossoDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Cristina PanuzzoDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Jessica PetitiDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.ORCID 0000-0001-8640-2462
Sonia CarturanDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Matteo DraganiDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Giacomo AndreaniDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.ORCID 0000-0003-4877-3929
Carmen FavaDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.ORCID 0000-0002-4896-981X
Giuseppe SaglioDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
Enrico BraccoDepartment of Oncology, University of Turin, 10043 Turin, Italy.ORCID 0000-0003-3170-2817
Daniela CilloniDepartment of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy. daniela.cilloni@unito.it.ORCID 0000-0001-6346-4791
University of Turin · IT

Funding

Daniela Cilloni 10100
6 · The paper itself

Abstract

In most of the acute myeloid leukemia patients there is an aberrant tyrosine kinase activity. The prototype of Sprouty proteins was originally identified in

Indexed as

acute myeloid leukemia (AML)FoxO3aSprouty1

Identifiers

PMID31277439
PMCPMC6678378
OpenAlexW2945820650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.